Company overview
Basic information
Company name
Conquistador Bioscience, MB
Company code
307132737
Registered address
Kaunas, Partizanų g. 61-806, LT-49282
Registration date
2025-03-27
Company age: 1 y. 6 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Manufacture of other food products n.e.c.
Ownership form
Private without foreign capital
Conquistador Bioscience, MB
Company code: 307132737
Address: Kaunas, Partizanų g. 61-806, LT-49282
Download a detailed company report
Make confident decisions with all the information about Conquistador Bioscience, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Conquistador Bioscience, MB is an operational private small partnership registered in 2025, with company code 307132737. It is classified as a micro company in the national private non-financial companies sector and operates under private ownership, where Lithuanian natural and legal persons hold more than 50% of the authorised capital and there is no foreign investor capital. Governance is CEO only. The company is based in Kaunas, Kauno m. sav., Kauno apskr., at Partizanu g. 61-806, LT-49282. Its registered activity under EVRK code C.10.89.00 is Manufacture of other food products n.e.c.
In its 2025 financial year, covering 279 days, the company reported revenue of EUR 35.9K and net profit of EUR 29.7K, resulting in a profit margin of 82.8%. Equity stood at EUR 29.7K, liabilities at EUR 5.0K, and total assets at EUR 34.7K. The reported ratios indicate a high equity position and strong profitability over the period. No employee averages are provided for the latest staff year so far in 2026.
In its 2025 financial year, covering 279 days, the company reported revenue of EUR 35.9K and net profit of EUR 29.7K, resulting in a profit margin of 82.8%. Equity stood at EUR 29.7K, liabilities at EUR 5.0K, and total assets at EUR 34.7K. The reported ratios indicate a high equity position and strong profitability over the period. No employee averages are provided for the latest staff year so far in 2026.